CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Cash flows from operating activities:
Net income	$ 318,489	$ 247,446	$ 267,335
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	79,456	64,039	56,868
Amortization of intangible and other assets	49,743	20,996	9,044
Amortization of deferred financing costs	7,045	8,023	428
Deferred income taxes	(65,527)	(88,402)	15,119
Share based compensation expense	22,187	20,947	18,803
Restructuring and other costs - non-cash	20,229	2,460	379
Stock option income tax benefit	(13,009)	(1,039)	(4,663)
Net interest expense on derivatives with an other than insignificant financing element	1,108	3,853	1,635
Income (Loss) from Equity Method Investments	3,270	(2,351)	1,096
Other non-cash expense (income)	(15,564)	20,938	6,153
Loss (gain) on disposal of property, plant and equipment	808	570	113
Changes in operating assets and liabilities, net of acquisitions:
Accounts and notes receivable-trade, net	(12,591)	1,469	5,115
Inventories, net	(36,792)	21,503	(9,309)
Prepaid expenses and other current assets	(15,126)	(933)	(3,705)
Other noncurrent assets	853	(1,560)	(1,154)
Accounts payable	12,843	10,816	2,165
Accrued liabilities	(2,084)	38,365	9,004
Income taxes	22,105	26,139	2,786
Other noncurrent liabilities	(7,758)	190	249
Net cash provided by operating activities	369,685	393,469	377,461
Cash flows from investing activities:
Cash paid for acquisitions of businesses and equity investments	(4,861)	(1,787,516)	(35,556)
Capital expenditures	(92,072)	(71,186)	(44,236)
Purchase of convertible debt issued by affiliate	0	0	(49,654)
Purchase of company owned life insurance policies	(1,577)	0	(2,000)
Payments on settlement of net investment hedges	(14,221)	(25,575)	(34,978)
Expenditures for identifiable intangible assets	(3,329)	(3,068)	(1,606)
Liquidations of short-term investments	0	6	0
Proceeds from sale of property, plant and equipment	1,039	497	3,562
Net cash used in investing activities	(115,021)	(1,886,842)	(164,468)
Cash flows from financing activities:
Proceeds from long-term borrowings, net of deferred financing costs	0	1,106,514	368,611
Payments on long-term borrowings	0	(251,932)	(242,137)
Increase (decrease) in short-term borrowings	(228,912)	270,209	(9,657)
Payments on terminated derivative instruments	0	(34,628)	0
Proceeds from exercise of stock options	34,183	42,275	30,189
Excess tax benefits from share based compensation	13,009	1,039	4,663
Cash paid for contingent consideration on prior acquisitions	(2,519)	(3,023)	0
Cash paid for acquisition of noncontrolling interests of consolidated subsidiaries	0	(16,088)	0
Cash paid for treasury stock	(38,837)	(79,500)	(223,993)
Cash dividends paid	(31,425)	(28,632)	(29,077)
Net interest payments on derivatives with an other-than-insignificant financing element	(1,108)	(3,853)	(1,635)
Net cash provided by (used in) financing activities	(255,609)	1,002,381	(103,036)
Effect of exchange rate changes on cash and cash equivalents	3,949	28,082	(20,267)
Net (decrease) increase in cash and cash equivalents	3,004	(462,910)	89,690
Cash and cash equivalents at beginning of period	77,128	540,038	450,348
Cash and cash equivalents at end of period	80,132	77,128	540,038
Supplemental disclosures of cash flow information:
Interest paid, net of amounts capitalized	60,166	34,048	21,856
Income taxes paid	$ 109,544	$ 58,646	$ 64,787